Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Net Income: 2018-2024

Historic Net Income for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to -$600.0 million.

  • Revolution Medicines' Net Income fell 95.28% to -$305.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$960.9 million, marking a year-over-year decrease of 69.46%. This contributed to the annual value of -$600.0 million for FY2024, which is 37.51% down from last year.
  • Latest data reveals that Revolution Medicines reported Net Income of -$600.0 million as of FY2024, which was down 37.51% from -$436.4 million recorded in FY2023.
  • In the past 5 years, Revolution Medicines' Net Income registered a high of -$108.2 million during FY2020, and its lowest value of -$600.0 million during FY2024.
  • Over the past 3 years, Revolution Medicines' median Net Income value was -$436.4 million (recorded in 2023), while the average stood at -$428.4 million.
  • Data for Revolution Medicines' Net Income shows a maximum YoY slumped of 126.92% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Revolution Medicines' Net Income stood at -$108.2 million in 2020, then crashed by 72.98% to -$187.1 million in 2021, then plummeted by 32.93% to -$248.7 million in 2022, then plummeted by 75.46% to -$436.4 million in 2023, then slumped by 37.51% to -$600.0 million in 2024.